Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Terminalia arjuna bark contains high concentrations of flavonoids (199 mg quercetin equivalent/g), phenolic compounds, and triterpenoids that exert cardioprotective effects through antioxidant activity and enzyme modulation. The bark's bioactive compounds scavenge free radicals, inhibit COX enzymes and inflammatory cytokines, and support cardiovascular function through glycoside-mediated cardiotonic activity.
Reported Benefits (Provisional)
Origin & History
Terminalia, a genus of large trees and shrubs, is widely distributed across tropical regions of Asia, Africa, and Australia. Various species within this genus, such as Terminalia arjuna and Terminalia chebula, are highly valued in functional nutrition for their bark's rich bioactive compounds, supporting cardiovascular and metabolic health.
Research Narrative (Provisional)
Extensive scientific research, including human clinical trials and meta-analyses, supports the cardioprotective, antioxidant, and anti-inflammatory effects of Terminalia species, particularly Terminalia arjuna. Studies also indicate its potential in metabolic regulation and liver support.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Tannins, polyphenols, flavonoids, triterpenes, alkaloids, plant sterols, saponins. - Minerals: Calcium, potassium, magnesium.
Reported Mechanism (Provisional)
Flavonoids including catechin, gallocatechin, and luteolin provide antioxidant activity by scavenging DPPH free radicals and upregulating catalase and glutathione peroxidase enzymes. Phenolic compounds like gallic acid and ellagic acid derivatives inhibit COX enzymes, prostaglandins, and inflammatory cytokines including IL-6 and TNF-alpha. Glycosides act as cardiotonics while triterpenoids like arjunolic acid contribute to cardiovascular protection through lipid metabolism regulation.
Clinical Narrative (Provisional)
Extensive research including human clinical trials and meta-analyses demonstrates cardioprotective, antioxidant, and anti-inflammatory effects, though specific quantified outcomes from controlled trials are not well-documented in current literature. Studies reference 60 articles supporting cardiovascular benefits, but lack detailed numerical endpoints such as ejection fraction improvements or specific cholesterol reduction percentages. Research confirms anti-ischemic and hypolipidemic effects in experimental and clinical settings. Further controlled trials with quantified outcomes are needed to establish definitive therapeutic parameters.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.